SIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.594800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.240040E-01
Normal-vs-Stage2
4.181000E-01
Normal-vs-Stage3
2.480600E-01
Normal-vs-Stage4
4.667600E-01
Stage1-vs-Stage2
4.576200E-01
Stage1-vs-Stage3
5.246400E-01
Stage1-vs-Stage4
7.078000E-01
Stage2-vs-Stage3
1.543830E-01
Stage2-vs-Stage4
8.371400E-01
Stage3-vs-Stage4
5.107800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.258200E-01
Normal-vs-AfricanAmerican
7.678300E-02
Normal-vs-Asian
3.888100E-02
Caucasian-vs-AfricanAmerican
1.800840E-01
Caucasian-vs-Asian
3.405800E-02
AfricanAmerican-vs-Asian
7.830600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.114800E-01
Normal-vs-Female
3.169200E-01
Male-vs-Female
4.607800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.644400E-01
Normal-vs-Age(41-60Yrs)
3.938400E-01
Normal-vs-Age(61-80Yrs)
3.329400E-01
Normal-vs-Age(81-100Yrs)
5.760200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.623600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.282200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.705800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.398040E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.111600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.504200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.929400E-01
Normal-vs-Daily Drinker
5.792800E-01
Normal-vs-Weekly Drinker
3.718200E-01
Normal-vs-Occasional Drinker
3.672400E-01
Normal-vs-Social Drinker
3.123400E-01
Non Drinker-vs-Daily Drinker
3.233800E-01
Non Drinker-vs-Weekly Drinker
7.185800E-01
Non Drinker-vs-Occasional Drinker
2.051600E-01
Non Drinker-vs-Social Drinker
6.689200E-01
Daily Drinker-vs-Weekly Drinker
3.060400E-01
Daily Drinker-vs-Occasional Drinker
9.710000E-01
Daily Drinker-vs-Social Drinker
6.185200E-01
Weekly Drinker-vs-Occasional Drinker
2.924400E-01
Weekly Drinker-vs-Social Drinker
5.422200E-01
Occasional Drinker-vs-Social Drinker
4.829200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.983000E-01
Normal-vs-Grade 2
8.912400E-01
Normal-vs-Grade 3
8.257800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.029700E-02
Grade 1-vs-Grade 3
6.917100E-03
Grade 1-vs-Grade 4
9.983000E-01
Grade 2-vs-Grade 3
1.356220E-01
Grade 2-vs-Grade 4
8.912400E-01
Grade 3-vs-Grade 4
8.257800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.347000E-01
Normal-vs-NonDiabetic
3.176000E-01
Diabetic-vs-NonDiabetic
9.207600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.158360E-01
Normal-vs-NoPancreatitis
3.575200E-01
Pancreatitis-vs-NoPancreatitis
2.156400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.043600E-01
Normal-vs-N1
4.491400E-01
N0-vs-N1
2.923800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.950000E-01
Normal-vs-TP53-NonMutant
2.468600E-01
TP53-Mutant-vs-TP53-NonMutant
2.262300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
